Hippocampal sclerosis revisited

Brain and Development

Volumn 20, Issue 8, 1998, Pages 563-573

  Fisher, Paul D ^a   Sperber, Ellen F ^a,b   Moshé, Solomon L ^a,b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

Development; Epilepsy; Febrile seizures; Hippocampal sclerosis; Human; Rat

Indexed keywords

DISEASE PREDISPOSITION; FEBRILE CONVULSION; HIPPOCAMPUS; HUMAN; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PELIZAEUS MERZBACHER DISEASE; REVIEW; SEIZURE; TEMPORAL LOBE EPILEPSY; TEMPORAL LOBECTOMY;

EID: 0031767806     PISSN: 03877604     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0387-7604(98)00069-2     Document Type: Article

References (108)

1. Dichter MA. The epilepsies and convulsive disorders. In: Isselbacher KJ, editor. Harrison's principles of internal medicine, thirteenth ed. New York: McGraw-Hill, 1994:2223-2233.
2. Shorvon S.D. The epidemiology and treatment of chronic and refractory epilepsy. Epilepsia. 37(Suppl. 2):1996;S1-S3.
3. Shamansky S.L., Glaser G.H. Socioeconomic characteristics of childhood seizure disorders in the New Haven area: an epidemiologic study. Epilepsia. 20:1979;457-474.
4. Wilder B.J. The treatment of epilepsy an overview of clinical practices. Neurology. 45(Suppl. 2):1995;S7-S11.
5. Berg A.T., Test F.M., Levy S.R., Shinnar S. The epidemiology of epilepsy: past, present, and future. Neurol Clin. 14:1996;383-398.
6. Margerison J.H., Corsellis J.A.N. Epilepsy and the temporal lobes. Brain. 89:1966;499-530.
7. Liu Z., Mikati M., Holmes G.L. Mesial temporal sclerosis: pathogenesis and significance. Pediatr Neurol. 12:1995;5-16.
8. Braak H., Braak E., Yilmazaar D., Bohl J. Functional anatomy of human hippocampal formation and related structures. J Child Neurol. 11:1996;265-275.
9. Sutula T., Cascino G., Cavazos J., Parada I., Ramirez L. Mossy fiber synaptic reorganization in the epileptic temporal lobe. Ann Neurol. 26:1989;321-330.
10. French J.A., Williamson P.D., Thadani V.M.et al. Characteristics of medial temporal lobe epilepsy: I. Results of history and physical examination. Ann Neurol. 34:1993;774-780.
11. Lothman E.W., Bertram E.H., Stringer J.L. Functional anatomy of hippocampal seizures. Prog Neurobiol. 37:1991;1-82.
12. Babb T.L., Lieb J.P., Brown J.W., Pretorius J., Crandall P.H. Distribution of pryamidal cell density and hyperexcitability in the epileptic human hippocampal formation. Epilepsia. 25:1984;721-728.
13. Mathern GW, Babb TL, Armstrong DL. Hippocampal sclerosis. In: Engel J, Pedley TA, editors. Epilepsy: a comprehensive textbook, Volume 1. Philadelphia, PA: Lippincott-Raven, 1997:133-155.
14. Dam A.M. Epilepsy and neuron loss in the hippocampus. Epilepsia. 21:1980;617-629.
15. Falconer M.A., Serafetinides E.A., Corsellis J.A.N. Etiology and pathogenesis of temporal lobe epilepsy. Arch Neurol. 10:1964;233-248.
16. Scheibel M.E., Crandall P.H., Scheibel A.B. The hippocampal-dentate complex in temporal lobe epilepsy. Epilepsia. 15:1974;55-80.
17. Babb L.T., Brown J.W., Pretorius J., Davenport C., Lieb J.P., Crandall P.H. Temporal lobe volumetric cell densities in temporal lobe epilepsy. Epilepsia. 25:1984;729-740.
18. Mathern G.W., Babb T.L., Mischel P.S.et al. Childhood generalized and mesial temporal epilepsies demonstrate different amounts and patterns of hippocampal neuron loss and mossy fiber synaptic reorganization. Brain. 119:1996;965-987.
19. Feindel W., Penfield W., Jasper H. Localization of epileptic discharge in temporal lobe automatism. Trans Am Neurol Assoc. 77:1952;14-17.
20. Olivier A. Temporal resections in the surgical treatment of epilepsy. In: Theodore WH, editor. Surgical treatment of epilepsy, Amsterdam: Elsevier Science, 1992:175-188.
21. Falconer MA. Mesial temporal (Ammon's horn) sclerosis as a common cause of epilepsy: aetiololgy, treatment, and prevention. Lancet 1974;2:767-770.
22. Bruton CJ. The neuropathology of temporal lobe epilepsy. New York: Oxford University Press, 1988.
23. Duncan J.S., Sagar H.J. Seizure characteristics, pathology, and outcome after temporal lobectomy. Neurology. 37:1987;405-409.
24. Sagar H.J., Oxbury J.M. Hippocampal neuron loss in temporal lobe epilepsy: correlation with early childhood convulsions. Ann Neurol. 22:1987;334-340.
25. Cendes F., Anderman F., Dubeau F.et al. Early childhood prolonged febrile convulsions, atrophy and sclerosis of mesial structures, and temporal lobe epilepsy: an MRI volumetric study. Neurology. 43:1993;1083-1087.
26. Mathieson G. Pathology of temporal lobe foci. Adv Neurobiol. 11:1975;163-181.
27. Mathern G.W., Babb T.L., Pretorius J.K., Melendez M., Levesque M.F. The pathologic relationships between lesion pathology, intracranial ictal EEG onsets, and hippocampal neuron losses in temporal lobe epilepsy. Epilepsy Res. 21:1995;133-147.
28. Mathern G.W., Babb T.L., Vickrey B.G., Melendaz M., Pretorius J.K. The clinical-pathogenic mechanisms of hippocampal neuron loss and surgical outcomes in temporal lobe epilepsy. Brain. 118:1995;105-118.
29. Marks D.A., Kim J., Spencer D.D., Spencer S.S. Characteristics of intractable seizures following meningitis and encephalitis. Neurology. 42:1992;1513-1518.
30. Berg A.T., Shinnar S. The risk of seizure recurrence following a first unprovoked seizure: a quantitative review. Neurology. 41:1991;965-972.
31. Shinnar S. Prolonged febrile seizures and mesial temporal sclerosis. Ann Neurol. 43:1998;211-212.
32. VanLandingham K.E., Heinz R.E., Cavazos J.E., Lewis D.V. Magnetic resonance imaging evidence of hippocampal injury after prolonged foca febrile convulsions. Ann Neurol. 43:1998;413-426.
33. Fernandez G., Effenberger O., Vinz B.et al. Hippocampal malformation as a cause of familial febrile convulsions and subsequent hippocampal sclerosis. Neurology. 50:1998;909-917.
34. Nadler J.V. Kainic acid as a tool for the study of temporal lobe epilepsy. Life Sci. 29:1981;2031-2042.
35. Nadler J.V., Perry B.W., Cotman C.W. Intraventricular kainic acid preferentially destroys hippocampal pyramidal cells. Nature. 27:1978;676-677.
36. Wuerthele S.M., Lovell K.L., Jones M.Z., Moore K.E. A histological study of kainic acid induced lesions in the rat brain. Brain Res. 149:1978;489-497.
37. Ben-Ari Y., Tremblay E., Ottersen O.P., Meldrum B.S. The role of epileptic activity in hippocampal and 'remote' cerebral lesions induced by kainic acid. Brain Res. 191:1980;79-97.
38. Lothman E.W., Collins R.C. Kainic acid induced limbic seizures: metabolic, behavioral, electoencephalographic, and neuropathological correlates. Brain Res. 218:1981;299-318.
39. Olney J.W., Fuller T., DeGubareff T. Acute dendrotoxic changes in the hippocampus of kainic treated rats. Brain Res. 176:1979;91-100.
40. Sloviter R.S., Damiano B.P. On the relationship between kainic acid-induced epileptiform activity and hippocampal neuron damage. Neuropharmacology. 20:1981;1003-1011.
41. Cavalheiro E.A., Riche D.A., Le Gal La Salle G. Long-term effects of intrahippocampal kainic acid injection in rats: a method for inducing spontaneous recurrent seizures. Electroenceph clin Neurophysiol. 53:1982;581-589.
42. Cronin J., Dudek E.F. Chronic seizures and collateral sprouting of dentate mossy fibers after kainic acid treatment in rats. Brain Res. 474:1988;181-184.
43. Turski W.A., Czuczwar S.J., Kleinrok Z., Turski L. Cholinomimetics produce seizures and brain damage in rats. Experientia. 39:1983;1408-1411.
44. Fujikawa D.G. The temporal evolution of neuronal damage from pilocarpine-induced status epilepticus. Brain Res. 725:1996;11-22.
45. Leite J.P., Bortolotto Z.A., Cavalheiro E.A. Spontaneous recurrent seizures in rats: an experimental model of partial epilepsy. Neurosci Behav Rev. 14:1990;511-517.
46. Cavalheiro E.A., Leite J.P., Bartolotto Z.A., Turski W.A., Ikonomido C., Turski L. Long-term effects of pilocarpine in rats: structural damage of the brain triggers kindling and spontaneous recurrent seizures. Epilepsia. 32:1991;778-782.
47. Cavazos J.E., Sutula T.P. Progressive neuronal loss induced by kindling: a possible mechanism for mossy fiber synaptic reorganization and hippocampal sclerosis. Brain Res. 527:1990;1-6.
48. Lipton S.A., Rosenberg P.A. Excitatory amino acids as a final common pathway for neurologic disorders. N Eng J Med. 330:1994;613-622.
49. Olney J.W. Glutamate-induced neuronal necrosis in the infant mouse hypothalamus. J Neuropathol Exp Neurol. 30:1970;75-90.
50. Olney J.W., Rhee V., Ho O.L. Kainic acid: a powerful neurotoxic analogue of glutamate. Brain Res. 77:1974;507-512.
51. Rothman S.M., Olney J.W. Excitotoxicity and the NMDA receptor. Trends Neurosci. 10:1987;299-302.
52. Koh J.Y., Goldberg M.P., Hartley D.M., Choir D.W. Non-NMDA-receptor-mediated neurotoxicity in cortical culture. J Neurosci. 10:1990;693-705.
53. Sloviter R.S., Dempster D.W. 'Epileptic' brain damage is replicated qualitatively in the rat hippocampus by central injection of glutamate or aspartate but not by GABA or acetylcholine. Brain Res Bull. 15:1985;39-60.
54. Dodd P.R., Bradford H.F. Release of amino acids from the maturing cobalt-induced epileptic focus. Brain Res. 11:1976;377-388.
55. Lallement G., Carptentier P., Callet A., Perot-Marino I., Baubichon D., Blanchet G. Effects of soman-induced seizures on different extracellular amino acid levels and on glutamate uptake in rat hippocampus. Brain Res. 563:1991;234-240.
56. Minamoto Y., Itano T., Tokuda M.et al. In vivo microdialysis of amino acid neurotransmitters in the hippocampus in amygdaloid kindled rat. Brain Res. 573:1992;345-348.
57. Millan M.H., Champman A.G., Meldrum B.S. Extracellular amino acid levels in hippocampus during pilocarpine-induced seizures. Epilepsy Res. 14:1993;139-148.
58. Carlson H., Ronne-Engstrom E., Ungerstedt U., Hillered L. Seizure related elevations of extracellular amino acids in human focal epilepsy. Neurosci Lett. 140:1992;30-32.
59. During M.J., Spencer D.D. Extracellular hippocampal spontaneous seizure in the conscious human brain. Lancet. 341:1993;1607-1610.
60. 3H] glutamate-binding sites in rat brain. J Neurosci. 5:1985;2909-2919.
61. Sloviter R.S., Sollas A.L., Barbaro N.M., Laxer K.D. Calcium-binding protein (calbindin-D28K) and parvalbumin immunocytochemistry in the normal and epileptic human hippocampus. J Comp Neurol. 308:1991;381-396.
62. A receptor gene expression in adult rat hippocampus: an in situ hybridization study. J Neurosci. 14:1994;2697-2707.
63. Sommer B., Seeburg P.H. Glutamate receptor channels: novel properties and new clones. Trends Pharmacol Sci. 13:1992;291-296.
64. 2+ permeability of KA-AMPA-gated glutamate receptor channels depends on subunit composition. Science. 252:1991;851-853.
65. Pollard H., Heron A., Moreau J., Ben-Ari Y., Khrestchatisky M. Alterations of the GluR-B AMPA receptor subunit flip/flop expression in kainate-induced epilepsy and ischemia. Neuroscience. 57:1993;545-554.
66. Friedman LK. Selective reduction in Glu2 protein in adult hippocampal CA3 neurons following status epilepticus but prior to cell loss. Hippocampus 1998;in press.
67. Sloviter R.S. Permanently altered hippocampal structure, excitability, and inhibition after experimental status epilepticus in the rat: the 'dormant basket cell' hypothesis and its possible relevance to temporal lobe epilepsy. Hippocampus. 1:1991;41-66.
68. Sloviter R.S. The functional organization of the hippocampal dentate gyrus and its relevance to the pathogenesis of temporal lobe epilepsy. Ann Neurol. 35:1994;640-654.
69. Sloviter R.S. Decreased hippocampal inhibition and a selective loss of interneurons in experimental epilepsy. Science. 235:1987;73-76.
70. McNamara J.O. Cellular and molecular basis of epilepsy. J Neurosci. 14:1994;3413-3425.
71. Robbins R.J., Brines M.L., Kim J.H.et al. A selective loss of somatostatin in the hippocampus of patients with temporal lobe epilepsy. Ann Neurol. 29:1991;325-332.
72. Mathern G.W., Babb T.L., Pretorius J.K., Leite J.P. Reactive synaptogenesis and neuron densities for neuropeptide Y, somatostatin, and glutamate decarboxylase immunoreactivity in the epileptogenic human fascia dentata. J Neurosci. 15:1995;3990-4004.
73. B receptors. J Neurosci. 16:1996;4250-4260.
74. Buckmaster P.S., Dudek F.E. Neuron loss, granule cell axon reorganization, and functional changes in the dentate gyrus of epileptic kainic-treated rats. J Comp Biol. 385:1997;385-404.
75. Nadler J.V., Perry B.W., Cotman C.W. Selective reinnervation of hippocampal area CA1 and the fascia dentata after destruction of CA3-CA4 afferents with kainic acid. Brain Res. 182:1980;1-9.
76. Tauck D.L., Nadler V.J. Evidence of functional mossy fiber sprouting in hippocampal formation of kainic acid-treated rats. J Neurosci. 5:1985;1016-1022.
77. Sutula T., Xioa-Xian H., Cavazos J., Scott G. Synaptic reorganization in the hippocampus induced by abnormal functional activity. Science. 239:1988;1147-1150.
78. Mathern G.W., Cifuente F., Leite J.P., Pretorius J.K., Babb T.L. Hippocampus EEG excitability and chronic spontaneous seizures are associated with aberrant synaptic reorganization in the rat intrahippocampal kainate model. Electroenceph clin Neurophysiol. 87:1993;326-339.
79. Mathern G.W., Pretorius J.K., Babb T.L. Quantified patterns of mossy fiber sprouting and neuron densities in hippocampal and lesional seizures. J Neurosurg. 82:1995;211-219.
80. Babb T.L., Kupfer W.R., Pretorius J.K. Recurrent excitatory circuits by 'sprouted' mossy fibers into the fascia dentate of human hippocampal epilepsy. Epilepsia. 29:1988;674.
81. Houser C.R., Miyashiro J.E., Swartz B.E., Walsh G.O., Rich J.R., Delgado-Escueta A.V. Altered patterns of dynorphin immunoreactivity suggest mossy fiber reorganization in human hippocampal epilepsy. J Neurosci. 26:1990;151-161.
82. Frank J.O., Pokorny J., Kunkel D.D., Schwartzkroin P.A. Physiologic and morphologic characteristics of granule cell circuitry in human epileptic hippocampus. Epilepsia. 36:1995;543-558.
83. Albala B.J., Moshé S.L., Okada R. Kainic-acid-induced seizures: a developmental study. Brain Res. 315:1984;139-148.
84. Tremblay E., Niteka L., Berger M.L., Ben-Ari Y. Maturation of kainic acid seizure-brain damage syndrome in the rat. I. Clinical, electrographic, and metabolic observations. Neuroscience. 13:1984;1051-1072.
85. Nitecka L., Tremblay E., Charton G., Bouillot J.P., Berger M.L., Ben-Ari Y. Maturation of kainate acid seizure-brain damage syndrome in the rat. II. Histopathological sequelae. Neuroscience. 13:1984;1073-1094.
86. Okada R., Moshé S.L., Albala B.J. Infantile status epilepticus and future seizure susceptibility in the rat. Brain Res. 317:1984;177-183.
87. Sperber E.F., Haas K.Z., Stanton P.K., Moshé S.L. Resistance of the immature hippocampus to seizure-induced synaptic reorganization. Brain Res Dev Brain Res. 60:1991;88-93.
88. Holmes G.L., Thompson J.L. Effects of kainic acid on seizure susceptibility in the developing brain. Brain Res Dev Brain Res. 39:1988;51-59.
89. Liu Z., Stafstrom C.E., Sarkisian M.et al. Age-dependent effects of glutamate toxicity in the hippocampus. Brain Res. 97:1996;178-184.
90. Cavalheiro E.A., Silva D.F., Turski W.A., Calderazzo-Filho L.S., Bortolotto Z.A., Turski L. The susceptibility of rats to pilocarpine-induced seizures is age-dependent. Brain Res Dev Brain Res. 37:1987;43-58.
91. A receptor gene expression in rat hippocampus following kainate- induced status epilepticus. Dev Neurosci. 19:1997;529-542.
92. Ackermann R.F., Lear J.L. Glycolysis-induced discordance between glucose metabolic rates measured with radiolabeled fluorodeoxyglucose and glucose. J Cerebral Blood Flow Metab. 9:1989;774-785.
93. Sperber E.F., Stanton P.K., Haas K., Ackermann R.F., Moshé S.L. Developmental differences in the neurobiology of epileptic brain damage. Epilepsy Res. 9S:1992;S67-S80.
94. Ehlers C.L., Henriksen S.J., Wang M., Rivier J., Vale W., Bloom F.E. Corticotropin releasing factor produces increases in brain excitability and convulsive seizures in rats. Brain Res. 278:1983;332-336.
95. Marrosu F., Fratta W., Carcangiu P., Giagheddu M., Gessa G.L. Localized epileptiform activity induced by murine CRF in rats. Epilepsia. 29:1988;369-373.
96. Baram T.Z., Schultz L. Corticotropin-releasing hormone is a rapid and potent convulsant in the infant rat. Brain Res Dev Brain Res. 61:1991;97-101.
97. Baram T.Z., Hirsch E., Snead C., Schultz L. Corticotropin-releasing hormone-induced seizures in infant rats originate in the amygdala. Ann Neurol. 31:1992;488-494.
98. Baram T.Z., Ribak C.E. Peptide-induced infant status epilepticus causes neuronal death and synaptic reorganization. NeuroReport. 6:1995;277-280.
99. Ribak C.E., Baram T.Z. Selective death of hippocampal CA3 pyramidal cells with mossy fiber afferents after CRH-induced status epilepticus in infant rats. Brain Res Dev Brain Res. 91:1996;245-251.
100. Sankar R., Shin D.H., Wasterlain C.G. Serum neuron-specific enolase is a marker for neuronal damage following staus epilepticus in the rat. Epilepsy Res. 28:1997;129-136.
101. Germano I.M., Zhang Y.F., Sperber E.F., Moshé S.L. Neuronal migration disorders increase susceptibility to hyperthermia-induced seizures in developing rats. Epilepsia. 37:1996;902-910.
102. Germano I.M., Sperber E.F. Increased seizure susceptibility in adult rats with neuronal migration disorders. Brain Res. 777:1997;219-222.
103. Berg A.T., Shinnar S. Unprovoked seizures in children with febrile seizures: short-term outcome. Neurology. 47:1996;562-568.
104. Knudsen F.U. Effective short-term diazepam prohylaxis in febrile convulsions. J Pediatr. 106:1985;487-490.
105. Wolf S.M., Forsythe A. Epilepsy and mental retardation following febrile seizures in childhood. Acta Paediatr Scand. 78:1989;291-295.
106. Knudsen F.U., Paerregaard A., Andersen R., Andersen J. Febrile seizures: treatment and outcome. Epilepsia. 36(Suppl. 3):1995;S216.
107. Corsellis AN, Bruton CJ. Status epilepticus. In: Advances in neurology 1983;34:129-139.
108. Sperber E.F., Haas K.Z., Moshé S.L. Developmental aspects of status epilepticus. Int Pediatr. 7:1992;213-222.